Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
mucin 1, cell surface associated | 0.384 | 0.885 | 1.9E-02 |
|
group | 0.100 | None | 1.000 | 9 | 0 | 1993 | 2020 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 7 | 0 | 1996 | 2019 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
group | 0.400 | None | 1.000 | 7 | 0 | 2002 | 2018 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.400 | None | 1.000 | 7 | 0 | 1993 | 2017 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
group | 0.370 | None | 1.000 | 6 | 0 | 2002 | 2017 | ||||||||
|
serpin family B member 5 | 0.582 | 0.577 | 3.6E-03 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2003 | 2009 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
group | 0.100 | None | 1.000 | 5 | 0 | 2002 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 1988 | 2018 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 1990 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.100 | None | 1.000 | 5 | 0 | 1995 | 2017 | ||||||||
|
vascular endothelial growth factor C | 0.459 | 0.769 | 0.50 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2002 | 2005 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 4 | 0 | 2002 | 2018 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
group | 0.100 | None | 1.000 | 3 | 0 | 1994 | 2015 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
group | 0.100 | None | 1.000 | 3 | 0 | 1995 | 2018 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
group | 0.070 | None | 1.000 | 3 | 0 | 2000 | 2010 | ||||||||
|
mitogen-activated protein kinase 3 | 0.379 | 0.885 | 3.7E-02 |
|
group | 0.040 | None | 1.000 | 3 | 0 | 2006 | 2015 | ||||||||
|
stratifin | 0.561 | 0.769 | 0.37 |
|
group | 0.060 | None | 1.000 | 3 | 0 | 2004 | 2019 | ||||||||
|
TIMP metallopeptidase inhibitor 3 | 0.445 | 0.923 | 0.63 |
|
group | 0.070 | None | 1.000 | 3 | 0 | 2000 | 2012 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
group | 0.360 | None | 1.000 | 3 | 0 | 2002 | 2019 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.100 | None | 1.000 | 3 | 0 | 1998 | 2015 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 1991 | 2017 | ||||||||
|
ERCC excision repair 2, TFIIH core complex helicase subunit | 0.420 | 0.846 | 7.1E-20 |
|
group | 0.050 | None | 1.000 | 3 | 0 | 2003 | 2010 | ||||||||
|
XPC complex subunit, DNA damage recognition and repair factor | 0.504 | 0.808 | 3.7E-11 |
|
group | 0.040 | None | 1.000 | 3 | 0 | 2006 | 2017 | ||||||||
|
thymidine phosphorylase | 0.495 | 0.769 | 1.2E-04 |
|
group | 0.060 | None | 1.000 | 3 | 0 | 2002 | 2015 | ||||||||
|
endothelial PAS domain protein 1 | 0.454 | 0.731 | 0.60 |
|
group | 0.060 | None | 1.000 | 3 | 0 | 2002 | 2017 |